Your browser doesn't support javascript.
loading
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.
Kuster, Simon; Jordan, Suzana; Elhai, Muriel; Held, Ulrike; Steigmiller, Klaus; Bruni, Cosimo; Cacciapaglia, Fabio; Vettori, Serena; Siegert, Elise; Rednic, Simona; Codullo, Veronica; Airo, Paolo; Braun-Moscovici, Yolanda; Hunzelmann, Nicolas; Joao Salvador, Maria; Riccieri, Valeria; Gheorghiu, Ana-Maria; Alegre Sancho, Juan José; Romanowska-Prochnicka, Katarzyna; Castellví, Ivan; Kötter, Ina; Truchetet, Marie-Elise; López-Longo, F J; Novikov, Pavel I; Giollo, Alessandro; Shirai, Yuichiro; Belloli, Laura; Zanatta, Elisabetta; Hachulla, Eric; Smith, Vanessa; Denton, Chris; Ionescu, Ruxandra M; Schmeiser, Tim; Distler, Joerg H W; Gabrielli, Armando; Hoffmann-Vold, Anna-Maria; Kuwana, Masataka; Allanore, Yannick; Distler, Oliver.
Afiliação
  • Kuster S; Department of Rheumatology; University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Jordan S; Department of Rheumatology; University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Elhai M; Department of Rheumatology; University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Held U; Department of Rheumatology, Paris Descartes University, Cochin Hospital, APHP, Paris, France.
  • Steigmiller K; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Bruni C; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Cacciapaglia F; Department of Rheumatology; University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Vettori S; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy.
  • Siegert E; Rheumatology Unit, DETO, University Hospital Polyclinic of Bari, Bari, Italy.
  • Rednic S; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Codullo V; Clinic for Rheumatology and Immunology, Bad Bramstedt, Germany.
  • Airo P; Berlin Institute of Health at Charité, Berlin, Germany.
  • Braun-Moscovici Y; Clinica Reumatologie, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Hunzelmann N; Department of Rheumatology, IRCCS Foundation Policlinico San Matteo, Pavia, Italy.
  • Joao Salvador M; UOC Rheumatology and Clinical Immunology, Spedali Civili di Brescia, Brescia, Italy.
  • Riccieri V; B. Shine Department of Rheumatology, Rambam Health Care Campus and Technion, Haifa, Israel.
  • Gheorghiu AM; University of Cologne, Cologne, Germany.
  • Alegre Sancho JJ; Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • Romanowska-Prochnicka K; Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
  • Castellví I; Department of Internal Medicine and Rheumatology, Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Kötter I; Department of Rheumatology, Hospital Peset, Valencia, Spain.
  • Truchetet ME; Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland.
  • López-Longo FJ; Department of Connective Tissues Diseases, Institute of Rheumatology, Warsaw, Poland.
  • Novikov PI; Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Giollo A; Clinic for Rheumatology and Immunology, Bad Bramstedt, Germany.
  • Shirai Y; University Hospital Hamburg-Eppendorf, Division of Rheumatology and Systemic Inflammatory Diseases, Hamburg, Germany.
  • Belloli L; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Zanatta E; Department of Rheumatology, National Reference Center for Systemic Autoimmune Rare Diseases, Hopital Pellegrin, Bordeaux, France.
  • Hachulla E; Department of Rheumatology, National Reference Center for Systemic Autoimmune Rare Diseases, Hopital Pellegrin, Bordeaux, France.
  • Smith V; Rheumatology Section, Department of Medicine, University of Verona, Verona, Italy.
  • Denton C; Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan.
  • Ionescu RM; Rheumatology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Schmeiser T; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy.
  • Distler JHW; Referral Centre for Rare Systemic Auto-immune Diseases for North and North-West of France, Department of Internal Medicine, Claude Huriez Hospital, University of Lille, Lille, France.
  • Gabrielli A; Department of Internal Medicine, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Hoffmann-Vold AM; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre (IRC), Ghent, Belgium.
  • Kuwana M; Centre for Rheumatology, University College London Medical School-Royal Free Campus, London, UK.
  • Allanore Y; Internal Medicine and Rheumatology Department-St. Maria Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Distler O; Krankenhaus St. Josef, Wuppertal-Elberfeld, Germany.
RMD Open ; 8(2)2022 11.
Article em En | MEDLINE | ID: mdl-36328401
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Escleroderma Sistêmico Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: RMD Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Escleroderma Sistêmico Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: RMD Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça